Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

December 19, 2025
The appeal of a dual-parasite combination vaccine
December 19, 2025
The future looks bright for malaria prevention
December 4, 2025
Disease outbreak survivors are key to future preparedness

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
November 19, 2025
Can AI safely support mental health?
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. Keeping covid vaccines cold isn’t easy. These ideas could help.
    New formulas and off-grid approaches could help mRNA vaccines get to more places around the world. PATH’s vaccine vial monitors are highlighted, and Pat Lennon explains the importance of thermostable vaccines in extending reach and access.
    Published: March 2021
  2. GFF launches $1.2B campaign for women's, children's health services
    Since the start of COVID-19, the Global Financing Facility for Women, Children, and Adolescents (GFF) has been sounding the alarm about the pandemic’s toll on women and children. PATH’s Pauline Irungu speaks to the impact in Kenya and the importance of en
    Published: March 2021
  3. A Covid-19 Vaccine Without a Needle? These Firms Are On the Case
    Research and development has ramped up to find novel methods for vaccine delivery. The goal? Replace the traditional needle-and-syringe method. PATH’s Manjari Lal explains why alternative technologies could improve mass immunization campaigns.
    Published: March 2021
  4. The other public health challenge
    Before COVID-19, the public health community in India was focused on eliminating tuberculosis (TB). PATH’s Shibu Vijayan explains how the COVID-19 pandemic sidetracked some TB efforts—and explores what it will take to get back on track.
    Published: February 2021
Previous
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

989 Item s
989 Item s
    Date
    From
    To
  1. Join PATH and the HepC3P project at the 14th International Conference on Health and Hepatitis in Substance Users
    At the 14th International Conference on Health and Hepatitis in Substance Users, PATH will highlight our work introducing innovative Hepatitis C virus prevention products and approaches, as well as roadmaps for advancing essential harm reduction services globally.
    Published: September 2026
    Press Release
  2. PATH and Global Fund take stock of antimalarial efficacy studies
    The Global Fund to Fight AIDS, Tuberculosis, and Malaria selects PATH to landscape, assess, and support antimalarial therapeutic efficacy studies across Sub-Saharan Africa.
    Published: September 2026
    Announcement
  3. PATH selected to lead Global Fund Integrated Surveillance grant
    The Global Fund to Fight AIDS, Tuberculosis and Malaria selects PATH to lead the Sustainable and Integrated Data Systems grant to support integration efforts in Zambia, Senegal, and Ghana.
    Published: September 2026
    Announcement
  4. PATH appoints Dr. Jeremy Farrar as Chief of Asia, Middle East, and Europe regional division
    Published: September 2026
    Press Release
  5. New SARS-CoV-1 antibody available for vaccine researchers
    Targeted antibodies can speed the development and testing of vaccines globally.
    Published: September 2026
    Press Release
Next